Scarica l'app Stockscreener
11.37
1.54%
0.1895
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$11.18
Aprire:
$11.21
Volume 24 ore:
677.41K
Relative Volume:
0.40
Capitalizzazione di mercato:
$1.34B
Reddito:
$260.81M
Utile/perdita netta:
$20.48M
Rapporto P/E:
87.46
EPS:
0.13
Flusso di cassa netto:
$22.67M
1 W Prestazione:
+1.91%
1M Prestazione:
+9.37%
6M Prestazione:
+15.84%
1 anno Prestazione:
-8.60%
Intervallo 1D:
$11.17
$11.38
Intervallo di 1 settimana:
$10.69
$11.38
Portata 52W:
$9.20
$14.63
Dynavax Technologies Corp Stock (DVAX) Company Profile
Nome
Dynavax Technologies Corp
Settore
Telefono
(510) 848-5100
Indirizzo
2100 POWELL STREET, EMERYVILLE, CA
Confronta DVAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
11.38 | 1.31B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
121.88 | 53.79B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.25 | 45.18B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.69 | 43.95B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.57 | 27.78B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
472.15 | 20.44B | 3.08B | 1.24B | 1.07B | 25.61 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-11 | Downgrade | Goldman | Neutral → Sell |
| 2024-02-01 | Iniziato | Goldman | Neutral |
| 2022-09-27 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-01-06 | Ripresa | Goldman | Buy |
| 2021-08-06 | Iniziato | Goldman | Buy |
| 2020-08-07 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-03 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-15 | Iniziato | Evercore ISI | Outperform |
| 2019-10-18 | Iniziato | H.C. Wainwright | Buy |
| 2019-07-11 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2019-02-27 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-05-10 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-03-08 | Reiterato | Cantor Fitzgerald | Overweight |
| 2018-02-14 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-09-25 | Reiterato | RBC Capital Mkts | Outperform |
| 2017-09-15 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-07-31 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2017-07-31 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2017-05-09 | Reiterato | RBC Capital Mkts | Sector Perform |
| 2016-04-28 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2016-04-27 | Downgrade | JP Morgan | Overweight → Neutral |
| 2015-11-30 | Iniziato | RBC Capital Mkts | Outperform |
| 2013-11-25 | Aggiornamento | MLV & Co | Hold → Buy |
| 2013-02-25 | Downgrade | MLV & Co | Buy → Hold |
| 2012-11-16 | Reiterato | MLV & Co | Buy |
Mostra tutto
Dynavax Technologies Corp Borsa (DVAX) Ultime notizie
Dynavax Technologies Corp (DYF1.SG) Stock Price, News, Quote & History - Yahoo! Finance Canada
Dynavax Technologies Corporatio (DVAX) Stock forecasts - Yahoo Finance UK
Dynavax Technologies Corporation (0IDA.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Dynavax Technologies Corporation (DYF1) stock a defensive play amid uncertainty2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Dynavax (Nasdaq: DVAX) to Join Evercore Healthcare Conference Fireside Chat on Dec. 2 - Stock Titan
Why Dynavax Technologies Corporation (DYF1) stock remains top ratedRate Hike & Low Risk Entry Point Tips - newser.com
Can Dynavax Technologies Corporation stock deliver consistent earnings growthWeekly Risk Summary & Precise Trade Entry Recommendations - newser.com
Is Dynavax Technologies Corporation showing signs of accumulation2025 Price Targets & Long-Term Investment Growth Plans - newser.com
Why Dynavax Technologies Corporation (DYF1) stock fits value portfoliosTake Profit & Technical Pattern Based Buy Signals - newser.com
Campbell & CO Investment Adviser LLC Sells 24,624 Shares of Dynavax Technologies Corporation $DVAX - Defense World
Can Dynavax Technologies Corporation stock reach $100 price targetSell Signal & Smart Allocation Stock Tips - newser.com
How Dynavax Technologies Corporation stock responds to policy changesWeekly Market Report & Low Drawdown Momentum Ideas - newser.com
Vaxart, Inc. Enters Exclusive License Agreement with Dynavax for COVID-19 Oral Vaccine Candidate, Completes Phase 2b Enrollment and Reports Q3 2025 Financial Results - Quiver Quantitative
Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results - Yahoo Finance
What institutional flow reveals about Dynavax Technologies CorporationWeekly Profit Report & Low Drawdown Investment Ideas - newser.com
Is Dynavax Technologies Corporation (DYF1) stock protected from inflationJuly 2025 Setups & AI Enhanced Trading Signals - newser.com
What dividend safety score for Dynavax Technologies Corporation stockInflation Watch & Verified Technical Signals - newser.com
What analysts say about Dynavax Technologies Corporation DYF1 stockDividend Growth Stocks & Trusted Financial Advisors at No Cost - earlytimes.in
What MACD and RSI say about Dynavax Technologies CorporationDollar Strength & Growth Focused Investment Plans - newser.com
Dynavax Technologies Corporatio (DVAX) Stock Forecasts - Yahoo Finance
Dynavax Technologies Corporation (NASDAQ:DVAX) Q3 2025 Earnings Call Transcript - Insider Monkey
Why Dynavax Technologies (DVAX) Is Up 5.7% After Launching a $100 Million Buyback and Raising Guidance - Yahoo Finance
Dynavax targets 60% U.S. hepatitis B market share by 2030 amid new COVID-19 vaccine deal and expanded share repurchase - MSN
Predicting Dynavax Technologies Corporation trend using moving averagesJuly 2025 Update & Fast Exit Strategy with Risk Control - newser.com
Will Dynavax Technologies Corporation stock remain a Wall Street favoriteWeekly Gains Summary & Weekly Breakout Stock Alerts - newser.com
Chart overlay techniques for tracking Dynavax Technologies CorporationEarnings Overview Report & Low Risk High Win Rate Picks - newser.com
Dynavax posts 13% rise in HEPLISAV-B revenue, announces $100 million buyback - Investing.com Nigeria
Dynavax Technologies: Q3 Earnings Snapshot - ctinsider.com
Dynavax Technologies Corp Azioni (DVAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Dynavax Technologies Corp Azioni (DVAX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Deep Track Biotechnology Maste | 10% Owner |
Aug 21 '25 |
Sale |
11.03 |
1,094,994 |
12,077,784 |
16,696,492 |
| Deep Track Biotechnology Maste | 10% Owner |
Aug 22 '25 |
Sale |
10.59 |
970,143 |
10,273,814 |
15,726,349 |
| Novack David F | President & COO |
Mar 24 '25 |
Option Exercise |
6.80 |
10,000 |
68,050 |
18,078 |
| Novack David F | President & COO |
Mar 24 '25 |
Sale |
14.00 |
10,000 |
140,000 |
8,078 |
6.35%
1.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):